These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. The structural requirements of histone deacetylase inhibitors: SAHA analogs modified at the C5 position display dual HDAC6/8 selectivity. Negmeldin AT; Pflum MKH Bioorg Med Chem Lett; 2017 Aug; 27(15):3254-3258. PubMed ID: 28648461 [TBL] [Abstract][Full Text] [Related]
24. Potent histone deacetylase inhibitors derived from 4-(aminomethyl)-N-hydroxybenzamide with high selectivity for the HDAC6 isoform. Blackburn C; Barrett C; Chin J; Garcia K; Gigstad K; Gould A; Gutierrez J; Harrison S; Hoar K; Lynch C; Rowland RS; Tsu C; Ringeling J; Xu H J Med Chem; 2013 Sep; 56(18):7201-11. PubMed ID: 23964961 [TBL] [Abstract][Full Text] [Related]
25. Preparation of a new construct of human histone deacetylase 8 for the crystallization of enzyme-inhibitor complexes. Porter NJ; Christianson DW Methods Enzymol; 2019; 626():561-585. PubMed ID: 31606091 [TBL] [Abstract][Full Text] [Related]
26. Novel Approaches Towards Designing of Isoform-Selective Inhibitors Against Class II Histone Deacetylases: The Acute Requirement for Targetted Anticancer Therapy. Ganai SA Curr Top Med Chem; 2016; 16(22):2441-52. PubMed ID: 26873193 [TBL] [Abstract][Full Text] [Related]
27. Histone deacetylase 11 suppresses p53 expression in pituitary tumor cells. Wang W; Fu L; Li S; Xu Z; Li X Cell Biol Int; 2017 Dec; 41(12):1290-1295. PubMed ID: 28782861 [TBL] [Abstract][Full Text] [Related]
28. Synthesis and Biological Investigation of Oxazole Hydroxamates as Highly Selective Histone Deacetylase 6 (HDAC6) Inhibitors. Senger J; Melesina J; Marek M; Romier C; Oehme I; Witt O; Sippl W; Jung M J Med Chem; 2016 Feb; 59(4):1545-55. PubMed ID: 26653328 [TBL] [Abstract][Full Text] [Related]
29. Histone deacetylases: structural determinants of inhibitor selectivity. Micelli C; Rastelli G Drug Discov Today; 2015 Jun; 20(6):718-35. PubMed ID: 25687212 [TBL] [Abstract][Full Text] [Related]
30. Target Design of Novel Histone Deacetylase 6 Selective Inhibitors with 2-Mercaptoquinazolinone as the Cap Moiety. Bui HTB; Nguyen PH; Pham QM; Tran HP; Tran Q; Jung H; Hong QV; Nguyen QC; Nguyen QP; Le HT; Yang SG Molecules; 2022 Mar; 27(7):. PubMed ID: 35408604 [TBL] [Abstract][Full Text] [Related]
32. Discovery of Potent and Isoform-selective Histone Deacetylase Inhibitors Using Structure-based Virtual Screening and Biological Evaluation. Peng Z; Zhao Q; Tian X; Lei T; Xiang R; Chen L; Yang Y Mol Inform; 2022 Sep; 41(9):e2100295. PubMed ID: 35224862 [TBL] [Abstract][Full Text] [Related]
33. HDAC11: a rising star in epigenetics. Liu SS; Wu F; Jin YM; Chang WQ; Xu TM Biomed Pharmacother; 2020 Nov; 131():110607. PubMed ID: 32841898 [TBL] [Abstract][Full Text] [Related]
34. HDAC11 inhibition disrupts porcine oocyte meiosis via regulating α-tubulin acetylation and histone modifications. Huang R; Sui L; Fu C; Zhai Y; Dai X; Zhang S; Li Z Aging (Albany NY); 2021 Mar; 13(6):8849-8864. PubMed ID: 33742608 [TBL] [Abstract][Full Text] [Related]
35. Inhibitory selectivity among class I HDACs has a major impact on inflammatory gene expression in macrophages. Cao F; Zwinderman MRH; van Merkerk R; Ettema PE; Quax WJ; Dekker FJ Eur J Med Chem; 2019 Sep; 177():457-466. PubMed ID: 31181405 [TBL] [Abstract][Full Text] [Related]
36. Diarylcyclopropane hydroxamic acid inhibitors of histone deacetylase 4 designed by combinatorial approach and QM/MM calculations. Kollar J; Frecer V J Mol Graph Model; 2018 Oct; 85():97-110. PubMed ID: 30145395 [TBL] [Abstract][Full Text] [Related]